|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Prepaid insurance | ||||
| Prepaid expenses | ||||
| Deferred offering costs | ||||
| Total current assets | ||||
| Marketable securities held in Trust Account | ||||
| Prepaid insurance - long term | ||||
| Prepaid expenses - long term | ||||
| TOTAL ASSETS | ||||
| LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES AND SHAREHOLDERS' DEFICIT: | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Due to Sponsor | ||||
| Promissory note - related party | ||||
| Total current liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 23,000,000 and 0 shares issued or outstanding, at redemption value of $10.23 and $0.00 at September 30, 2026 and December 31, 2025, respectively | ||||
| Class A Ordinary Shares | ||||
| Total class A ordinary shares subject to possible redemption, 23,000,000 and 0 shares issued or outstanding, at redemption value of $10.23 and $0.00 at September 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders' Deficit: | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders' Deficit | ||||
| TOTAL LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES AND SHAREHOLDERS' DEFICIT |
Loading...